Antihyperuricemic lignans from the leaves of Phyllanthus niruri

Planta Medica

Volumn 72, Issue 14, 2006, Pages 1262-1267

  Murugaiyah, Vikneswaran ^a   Chan, Kit Lam ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Antihyperuricemic activity; Euphorbiaceae; Hyperuricemic rats; Lignans; Phyllanthus niruri L.; Plasma uric acid analysis

Indexed keywords

ALLOPURINOL; BENZBROMARONE; HERBACEOUS AGENT; HYPOPHYLLANTIN; LIGNAN DERIVATIVE; METHANOL EXTRACTION RESIDUE; OXONATE POTASSIUM; PHYLLANTIN; PHYLLANTUS NIRURI EXTRACT; PHYLTETRALIN; PLANT EXTRACT; PROBENECID; UNCLASSIFIED DRUG; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG STRUCTURE; FRACTIONATION; HYPERURICEMIA; MALE; MEDICINAL PLANT; NONHUMAN; PHYLLANTUS NIRURI; PLANT LEAF; RAT; URIC ACID BLOOD LEVEL;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GOUT; LIGNANS; MALE; PHYLLANTHUS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, SPRAGUE-DAWLEY; URIC ACID; URICOSURIC AGENTS;

ANIMALIA; EUPHORBIACEAE; PHYLLANTHUS NIRURI;

EID: 33845266168     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-947224     Document Type: Article

References (24)

1. Ghei M, Mihailescu M, Levinson D. Pathogenesis of hyperuricemia: Recent advances. Curr Rheumatol Rep 2002; 4: 270-4
2. Mazzali M, Hughes J, Kim YG, Jefferson A, Kang DH, Gordon KL et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38: 1101-6
3. Zhu JX, Wang Y, Kong LD, Yang C, Zhang X. Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver. J Ethnopharmacol 2004; 93: 133-40
4. Dincer HE, Dincer AP, Levinson DJ. Asymptomatic hyperuricemia: To treat or not to treat. Cleveland Clin J Med 2002; 69: 594-608
5. Khoo BP, Leow YH. A review of inpatients with adverse drug reactions to allopurinol. Singapore Med J 2000; 41: 156-60
6. Adel G. Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient. Curr Rheumatol Rep 2001; 3: 29-35
7. Perez-Ruiz F, Alonso-Ruiz A, Calabozo M, Herrero-Beites A, Garcia-Erauskin G, Ruiz-Lucea E. Efficacy of allopurinol and benzbromarone for the control of hyperuricemia. A pathogenic approach to the treatment of primary chronic gout. Ann Rheum Dis 1998; 57: 545-9
8. Owen PL, Johns T. Xanthine oxidase inhibitory activity of northeastern North American plant remedies used for gout. J Ethnopharmacol 1999; 64: 149-60
9. Kong LD, Cai Y, Huang WW, Cheng CHK, Tan RX. Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J Ethnopharmacol 2000; 73: 199-207
10. Nguyen MTT, Awale S, Tezuka Y, Tran QL, Watanabe H, Kadota S. Xanthine oxidase Inhibitory activity of Vietnamese Medicinal Plants. Biol Pharm Bull 2004; 27: 1414-21
11. Jalil J, Jantan I, Husain K, Jamal JA, Salleh MS. Tumbuhan ubatan untuk merawat reumatisme. In: Rahmani M, Mahmood M, Sukari MA, Lian GEC, Hin TYY, Ali DAI, editors. Proceedings of the 16th National Seminar of Natural Products Malaysia: Universiti Putra Malaysia, 2000: p 146-52
12. Kong LD, Yang C, Ge F, Wang HD, Guo YS. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J Ethnopharmacol 2004; 93: 325-30
13. Kong LD, Zhou J, Wen Y, Li J, Cheng CHK. Aesculin possess potent hypouricemic action in rodents but is devoid of xanthine oxidase/dehydrogenase inhibitory activity. Planta Med 2002; 68: 175-8
14. Ding Z, Dai Y, Wang Z. Hypouricemic action of scopoletin arising from xanthine oxidase inhibition and uricosuric activity. Planta Med 2005; 71: 183-5
15. Murugaiyah V, Chan KL. Screening for in vivo antihyperuricemic activity in several Malaysian plants. J Ethnopharmacol, in press,
16. Unader DW, Webster GL, Blumberg BS. Uses and bioassays in Phyllanthus (Euphorbiaceae): a compilation II. The subgenus Phyllanthus. J Ethnopharmacol 1991; 34: 97-133
17. 13C-NMR assignments of phyllanthin and hypophyllanthin: Lignans that enhance cytotoxic responses with cultured multidrug-resistant cells. J Nat Prod 1993; 56: 233-9
18. Anjaneyulu ASR, Rao KJ, Row LR, Subrahmanyam C. Crystalline constituents of Euphorbiaceae - XII: Isolation and structural elucidation of three new lignans from the leaves of Phyllanthus niruri Linn. Tetrahedron 1973; 29: 1291-8
19. Ward RS, Satyanarayana P, Row LR, Rao BVG. The case of revised structure for hypophyllanthin - An analysis of the 13 NMR spectra of aryltetralins. Tetrahedron Lett 1979; 32: 3046
20. Satyanarayana P, Venkateswarlu S, Viswanathan KN. Oxidative aryl-aryl, aryl-benzyl coupling of lignans-reactions of phyllanthin and haloderivatives with TTFA, DDQ, Li/THF: Synthesis of dibenzocyclooctadiene system and phyltetralin. Tetrahedron 1991; 38: 8277-84
21. Yamada H, Kotaki H, Furitsu H, Sawada Y, Iga T. Mechanism of the uricosuric action of the anti-inflammatory drug E3040 used to treat inflammatory bowel disease I: Study using a rat model of hyperuricemia. Biopharm Drug Dispos 1999; 20: 77-83
22. Yonetani Y, Iwaki K. Effects of uricosuric drugs and diuretics on uric acid excretion in oxonate-treated rats. Japan J Pharmacol 1983; 33: 947-54
23. Hollinger MA. CRC Handbook of Toxicology. New York: CRC Press, 1995: p 783
24. Di Carlo G, Autore G, Izzo AA, Maiolino P, Mascolo N, Viola P et al. Inhibition of intestinal motility and secretion by flavonoids in mice and rats: structure-activity relationships. J Pharm Pharmacol 1993; 45: 1054-9